13F HOLDINGS REPORT
ARCH Venture Management, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001012975-25-000245
Total Value
$206.2M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC. | BEAM | 4,540,132 | $88.7M | 43.00% |
| 2 | MAZE THERAPEUTICS, INC. | MAZE | 4,120,053 | $45.4M | 22.00% |
| 3 | RAPPORT THERAPEUTICS, INC. | RAPP | 3,728,738 | $37.5M | 18.21% |
| 4 | ERASCA, INC. | ERAS | 11,055,554 | $15.1M | 7.34% |
| 5 | VERVE THERAPEUTICS, INC. | 92539P101 | 2,008,809 | $9.1M | 4.42% |
| 6 | GOSSAMER BIO, INC. | GOSS | 8,055,916 | $8.8M | 4.26% |
| 7 | UNITY BIOTECHNOLOGY, INC. | UNTCW | 1,004,817 | $1.0M | 0.51% |
| 8 | Q32 BIO INC. | QTTB | 320,482 | $532,000 | 0.26% |
| 9 | CERO THERAPEUTICS HOLDINGS, INC. | CEROW | 22,102 | $16,134 | 0.01% |